Andrew J. Coldman

11.0k total citations
140 papers, 7.6k citations indexed

About

Andrew J. Coldman is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Andrew J. Coldman has authored 140 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Oncology, 43 papers in Epidemiology and 21 papers in Cancer Research. Recurrent topics in Andrew J. Coldman's work include Global Cancer Incidence and Screening (49 papers), Cervical Cancer and HPV Research (37 papers) and Colorectal Cancer Screening and Detection (33 papers). Andrew J. Coldman is often cited by papers focused on Global Cancer Incidence and Screening (49 papers), Cervical Cancer and HPV Research (37 papers) and Colorectal Cancer Screening and Detection (33 papers). Andrew J. Coldman collaborates with scholars based in Canada, United States and Australia. Andrew J. Coldman's co-authors include James H. Goldie, J.H. Goldie, Randy D. Gascoyne, David I. McLean, Joseph M. Connors, Richard P. Gallagher, Ivo A. Olivotto, Chris Bajdik, Norm Phillips and Vincent Ng and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Andrew J. Coldman

137 papers receiving 7.3k citations

Peers

Countries citing papers authored by Andrew J. Coldman

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Coldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Coldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Coldman more than expected).

Fields of papers citing papers by Andrew J. Coldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Coldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Coldman. The network helps show where Andrew J. Coldman may publish in the future.

Co-authorship network of co-authors of Andrew J. Coldman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Coldman. A scholar is included among the top collaborators of Andrew J. Coldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Coldman. Andrew J. Coldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shooting for the Moon: Can We Cut Cancer Mortality in Canada By 50% By 2050? 2025 ·Cancer Control ·(unknown), Yibing Ruan, (unknown), (unknown), (unknown), Matthew T. Warkentin, Andrew J. Coldman, Rochelle Garner, Hawre Jalal, Darren R. Brenner	0
2	Examining breast cancer screening recommendations in Canada: The projected resource impact of screening among women aged 40–49 2024 ·Journal of Medical Screening ·(unknown), Yibing Ruan, (unknown), Matthew T. Warkentin, Oğuzhan Alagöz, Andrew J. Coldman, Darren R. Brenner	0
3	Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial 2021 ·Cancer Medicine ·(unknown), Laurie Smith, (unknown), Lindsay Hedden, Andrew J. Coldman, Darrel Cook, Eduardo L. Franco, Mel Krajden, Ruth Elwood Martin, Marette Lee, Gavin Stuart, Dirk van Niekerk, Gina Ogilvie, Stuart Peacock	14
4	Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Anna Gottschlich, Dirk van Niekerk, Laurie Smith, Lovedeep Gondara, Joy Melnikow, Darrel Cook, Marette Lee, Gavin Stuart, Ruth Elwood Martin, Stuart Peacock, Eduardo L. Franco, Andrew J. Coldman, Mel Krajden, Gina Ogilvie	16
5	Disease detection at the 48‐month exit round of the HPV FOCAL cervical cancer screening trial in women per‐protocol eligible for routine screening 2019 ·International Journal of Cancer ·Andrew J. Coldman, Dirk van Niekerk, Mel Krajden, Laurie Smith, Darrel Cook, Lovedeep Gondara, Kathy Ceballos, (unknown), Marette Lee, (unknown), Laura Gentile, Stuart Peacock, Gavin Stuart, Eduardo L. Franco, Gina Ogilvie	2
6	Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial 2018 ·Journal of Clinical Virology ·Darrel Cook, Laurie Smith, Jennifer Law, (unknown), Lovedeep Gondara, Dirk J. van Niekerk, Kathy Ceballos, Dan Jang, Max Chernesky, Eduardo L. Franco, Gina Ogilvie, Andrew J. Coldman, Mel Krajden	15
7	Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial 2018 ·Obstetrical & Gynecological Survey ·Gina Ogilvie, Dirk van Niekerk, Mel Krajden, Laurie Smith, Darrel Cook, Lovedeep Gondara, Kathy Ceballos, David Quinlan, Marette Lee, Ruth Elwood Martin, Laura Gentile, Stuart Peacock, Gavin Stuart, Eduardo L. Franco, Andrew J. Coldman	32
8	Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial 2018 ·International Journal of Cancer ·Darrel Cook, Mel Krajden, Adam R. Brentnall, Lovedeep Gondara, Tracy Chan, Jennifer Law, Laurie Smith, Dirk J. van Niekerk, Gina Ogilvie, Andrew J. Coldman, (unknown), Caroline Reuter, Jack Cuzick, Attila T. Lörincz	60
9	The OncoSim Model: Development and Use for Better Decision-Making in Canadian Cancer Control 2017 ·Current Oncology ·Cindy L. Gauvreau, (unknown), S. Memon, W. Michael Flanagan, (unknown), (unknown), Rochelle Garner, Anthony B. Miller, William K. Evans, Cathy Popadiuk, Michael Wolfson, Andrew J. Coldman	30
10	Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial 2016 ·Journal of Obstetrics and Gynaecology Canada ·Laurie Smith, Dirk van Niekerk, Andrew J. Coldman, Mel Krajden, Eduardo L. Franco, Gina Ogilvie	6
11	Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer 2014 ·JNCI Journal of the National Cancer Institute ·Andrew J. Coldman, Norm Phillips, Christine Wilson, Kathleen Decker, Anna M. Chiarelli, Jacques Brisson, Bin Zhang, Jennifer Payne, Gregory Doyle, (unknown)	189
12	Local and Regional Therapy for Women with Breast Cancer in British Columbia 2003 ·The Breast Journal ·T. Gregory Hislop, Andrew J. Coldman, Ivo A. Olivotto, Yulia Dyachkova, Caroline Speers	8
13	Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer 2003 ·Human Pathology ·Nikita Makretsov, C. Blake Gilks, Andrew J. Coldman, Malcolm Hayes, David Huntsman	93
14	Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes 2002 ·The American Journal of Surgery ·P. Terry Phang, John K. MacFarlane, Robert H. Taylor, Rona Cheifetz, Noelle Davis, John Hay, (unknown), Caroline Speers, (unknown), (unknown), Andrew J. Coldman	30
15	Efficacy of Sunscreen in Preventing Nevi—Reply 2000 ·JAMA ·Richard P. Gallagher, Chris Bajdik, Tim K. Lee, Jason K. Rivers, David I. McLean, Andrew J. Coldman	2
16	Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. 1996 ·PubMed ·Richard P. Gallagher, Chris Bajdik, S Fincham, Gerry Hill, (unknown), Andrew J. Coldman, David I. McLean	64
17	Melanocytic nevus density in Asian, Indo-Pakistani, and white children: The Vancouver Mole Study 1991 ·Journal of the American Academy of Dermatology ·Richard P. Gallagher, Jason K. Rivers, C. Paul Yang, David I. McLean, Andrew J. Coldman, Hulbert K. B. Silver	28
18	Incidence and risk factors for second breast primaries in women with lobular breast carcinoma 1990 ·Breast Disease ·T. Gregory Hislop, Vincent Ng, Mary L. McBride, Andrew J. Coldman, (unknown)	1
19	Neoadjuvant (preoperative) chemotherapy for breast cancer 1985 ·Cancer ·Joseph Ragaz, Robert Baird, (unknown), James H. Goldie, Andrew J. Coldman, John Spinelli	30
20	Clinical Indicators of Prognosis in Unresected Lung Cancer 1981 ·CHEST Journal ·Peter Coy, Mark Elwood, Andrew J. Coldman	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact